Accessibility Menu
Gerresheimer Ag logo

Gerresheimer Ag(OTC) GRRMF

Market Cap$1.09BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2009)+47%
5 Year-68%
1 Year-39%
1 Month+3%
$31.68
+0.00%
+0.00Today
Gerresheimer Ag last closing stock price
MetricPriceDate
Last closeUSD 31.682026-07-31
Gerresheimer Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.83%USD 30.812026-07-21
1 month+3.09%USD 30.732026-06-30
3 month+53.41%USD 20.652026-04-27
Year to date-13.98%USD 36.832025-11-12
1 year-38.82%USD 51.782025-07-29
3 year-73.38%USD 118.992023-07-24
5 year-67.87%USD 98.602021-07-21
Since inception+46.79%USD 21.582009-02-12

Gerresheimer Ag Financials at a Glance

Market Cap

$1.09BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€2.32B

Net Income (TTM)

-€320.32M

EPS (TTM)

-$10.76

P/E Ratio

-2.94

Dividend

$0.00

Beta (Volatility)

-0.15 (Low)

Price

$31.68

Volume

300

Open

$31.68

Previous Close

$31.68

Daily Range

$31.68 - $31.68

52-Week Range

$19.17 - $51.65

Estimated Earnings Date

Jul 14, 2026

GRRMF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Gerresheimer Ag

Gerresheimer AG is a leading manufacturer of packaging solutions and drug delivery devices, serving the pharmaceutical, biotechnology, diagnostics, and medical technology sectors. Established in 1864 and headquartered in Düsseldorf, Germany, the company operates through three primary divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies.

Products and Services
  • Comprehensive drug delivery systems, including inhalers and prefillable syringes
  • Essential glass packaging for pharmaceuticals and cosmetics
  • Innovative smart drug delivery systems, such as micro-pumps
Growth Outlook
  • Revenue increased to €639 million in Q4 2025, showing strong demand
  • Operating income improved to €7.4 million in Q3 2025, indicating operational efficiency
  • Investment in R&D reached €71 million in Q4 2025, supporting future innovations
Financial Highlights
  • Trailing twelve months (TTM) revenue of €2.4 billion, reflecting steady growth
  • Net income for Q4 2025 was -€306.6 million, highlighting recent challenges
  • Cash flow from operations was €89.7 million in Q4 2025, indicating liquidity
Gerresheimer AG has established itself as a key player in the healthcare packaging industry, with a diverse product portfolio that caters to various sectors. The company's focus on innovation, particularly in smart drug delivery systems, positions it well for future growth. Despite facing recent financial challenges, the increase in revenue and operational cash flow suggests resilience and potential for recovery. The commitment to research and development further underscores the company's strategy to enhance its offerings and maintain a competitive edge in the market.
AI Generated • Jul 25, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

13,528

CEO

Uwe Ferdinand Röhrhoff

Website

www.gerresheimer.com

Headquarters

Düsseldorf, NW 40468, DE

GRRMF Financials

Key Financial Metrics (TTM)

Gross Margin

18.32%

Operating Margin

-9.02%

Net Income Margin

-13.80%

Return on Equity

-23.57%

Return on Capital

-6.19%

Return on Assets

-7.13%

Earnings Yield

-34.01%

Dividend Yield

0.00%

Payout Ratio

-1.05%

Stock Overview

Market Cap

$1.09BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

34.54M

Volume

300

Avg. Volume

32.762

Financials (TTM)

Gross Profit

€548.29M

Operating Income

-€209.32M

EBITDA

€358.24M

Operating Cash Flow

€209.53M

Capital Expenditure

-€678.48M

Free Cash Flow

-€98.80M

Cash & ST Invst.

€176.21M

Total Debt

€2.30B

Gerresheimer Ag Performance Analysis

Gerresheimer Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-11-30EUR 1,920,956,7947.8%
20232023-11-30EUR 2,146,348,09511.7%
20242024-11-30EUR 2,161,363,6920.7%
20252025-11-30EUR 2,593,422,24120.0%
Gerresheimer Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-02-28-8.6%
Q22025-05-3115.5%
Q32025-08-31-6.7%
Q42025-11-3014.1%
Gerresheimer Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-11-30EUR 3.241.9%
20232023-11-30EUR 3.7616.1%
20242024-11-30EUR 2.59-31.2%
20252025-11-30EUR -10.36N/A
Gerresheimer Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-02-28-148.1%
Q22025-05-31194.2%
Q32025-08-31-175.5%
Q42025-11-30-2300.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

€639.49M

+12.4%

Gross Profit

€124.82M

-31.3%

Gross Margin

19.52%

N/A

Market Cap

$1.09BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$80.89K

N/A

Employees

13,528

N/A

Net Income

-€306.63M

-927.8%

EBITDA

€80.36M

-31.4%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

€176.21M

-17.3%

Total Debt

€2.30B

+79.6%

Accounts Receivable

€342.64M

+2.5%

Inventory

€450.36M

+28.8%

Long Term Debt

€1.60B

+74.6%

Short Term Debt

€703.01M

+92.0%

Return on Assets

-7.13%

N/A

Return on Invested Capital

-6.68%

N/A

Free Cash Flow

€31.83M

-27.5%

Operating Cash Flow

€89.74M

-32.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BOEUFBonesupport Holding AB (publ)
$20.49+0.00%
GTBIFGreen Thumb Industries Inc.
$7.10+1.28%
ZRSEFDocMorris AG
$10.24+0.00%
EKTAFElekta AB (publ)
$5.18-1.33%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About GRRMF

What is the current price of Gerresheimer Ag?

Gerresheimer Ag is trading at $31.68 per share.

What is the 52-week range for Gerresheimer Ag?

Over the past 52 weeks, Gerresheimer Ag has traded between $19.17 and $51.65.

How much debt does Gerresheimer Ag have?

As of the most recent reporting period, Gerresheimer Ag reported total debt of €2.53B.

How much cash does Gerresheimer Ag have on hand?

Gerresheimer Ag reported €204.50M in cash and cash equivalents in its most recent financial results.

What is Gerresheimer Ag’s dividend yield?

Gerresheimer Ag does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services